In this work, it is a very interesting and promising finding that our results showed the KIRC samples harboring RIPK2 over-expression enriched in the somatics mutants of gene SETD2 and BAP1, these results provided potential interaction between RIPK2 and these two well-known oncogenes of kidney cancer [24, 25]. Here, RIPK2 is linked to kidney cancer.